|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 13, Issue 6, 1846-1856, June 2002






Division of Molecular Cell Biology, Department of
Biology, University of Oslo, 0316 Oslo, Norway; *Centre
d'Immunologie de Marseille-Luminy, Centre National de la Recherche
Scientifique-INSERM-Univ-Med, 13288 Marseille, Cedex 09, France; and
§Istituto di Chimica Biomolecolare del Consiglio Nazionale
delle Ricerche, Comprensorio Olivetti, I-80078 Pozzuoli (Napoli), Italy
| |
ABSTRACT |
|---|
|
|
|---|
The major histocompatibility complex class II associated invariant chain (Ii) has been shown to inhibit endocytic transport and to increase the size of endosomes. We have recently found that this property has a significant impact on antigen processing and presentation. Here, we show in a cell-free endosome fusion assay that expression of Ii can increase fusion after phosphatidylinositol 3-kinase activity is blocked by wortmannin. In live cells wortmannin was also not able to block formation of the Ii-induced enlarged endosomes. The effects of Ii on endosomal transport and morphology depend on elements within the cytoplasmic tail. Data from mutagenesis analysis and nuclear magnetic resonance-based structure calculations of the Ii cytoplasmic tail demonstrate that free negative charges that are not involved in internal salt bridges are essential for both interactions between the tails and for the formation of enlarged endosomes. This correlation indicates that it is interactions between the Ii cytoplasmic tails that are involved in endosome fusion. The combined data from live cells, cell-free assays, and molecular dynamic simulations suggest that Ii molecules on different vesicles can promote endosome docking and fusion and thereby control endosomal traffic of membrane proteins and endosomal content.
| |
INTRODUCTION |
|---|
|
|
|---|
Invariant chain (Ii) is a type II transmembrane
glycoprotein known to have several important functions in antigen
presentation (for a review see Germain, 1994
; Nordeng et
al., 1998
). In the endoplasmic reticulum (ER) Ii trimers
transiently associate with major histocompatibility complex (MHC) class
II 
10 dimers. MHC class II molecules are transported from the ER
to the endocytic pathway where they encounter endocytosed antigens. Two
Leu-based-sorting signals in the cytoplasmic tail are independently
sufficient for efficient endosomal targeting of Ii (Pieters et
al., 1993
; Bremnes et al., 1994
; Odorizzi et
al., 1994
). During intracellular transport of 
-Ii complexes,
Ii is sequentially degraded from the luminal side (Blum and Cresswell,
1988
). Partially degraded Ii remains trimeric and still associated with
MHC class II, suggesting that the luminal region is not required for
maintaining the nonameric 
-Ii complex (Amigorena et
al., 1995
; Newcomb et al., 1996
).
At high levels of expression, Ii has been reported to accumulate in
enlarged endosomal compartments in transfected cells (Pieters et
al., 1993
; Romagnoli et al., 1993
). In addition, Ii
expression has been shown to cause a delayed endocytic transport of
both antigens and membrane proteins in transfected cells (Romagnoli et al., 1993
; Gorvel et al., 1995
; Gregers,
Nordeng, Gilje, Sandlie, and Bakke, unpublished data). These
results demonstrate that Ii can modify the structure and function of
the endosomal compartment, and this could influence antigen processing
and presentation. A morphological study of Ii-induced large endosomal
vesicle(s) (ILEV) in a human fibroblast cell line demonstrated that
enlarged compartments containing early endosomal markers appeared as
single membrane vesicles, whereas those containing late markers were generally filled with internal membranes (Stang and Bakke, 1997
). Chimeric proteins consisting of the Ii tail fused to reporter molecules
that formed tetramers did not induce vacuolation (Pieters et
al., 1993
; Bremnes et al., 1994
). In addition, Ii
constructs unable to trimerize were localized in normal-sized
endosomes, showing that the luminal region of Ii was involved in
Ii-induced vacuolation (Gedde-Dahl et al., 1997
). Nuclear
magnetic resonance (NMR) studies of a synthetic Ii tail peptide have
shown that it takes up an
-helix (Motta et al., 1995
) and
that this peptide at high concentration forms a trimeric aggregate
(Motta et al., 1997
). Together, these data indicate that Ii
trimers are formed by interactions both in its cytoplasmic tail and in
the luminal domain.
It has previously been reported that ILEV were not formed in cells
expressing a mutant Ii construct lacking the 11 N-terminal amino acids
(Pieters et al., 1993
; Romagnoli et al., 1993
),
and Pond et al. (1995)
showed that acidic amino acid
residues upstream of the membrane-distal Leu-based-sorting signal were
required for endocytic targeting and vacuolation. In this study, we
have further investigated the sequence and the structural requirements within the cytoplasmic tail of Ii that are essential for Ii-induced endosomal vacuolation. Using a cell-free system we have also addressed the mechanisms by which Ii is able to regulate size and morphology of endosomes.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Recombinant cDNA Constructs
The cDNA fragment encoding the p33 form of human Ii
(Iiwt) has been described previously (Bakke and
Dobberstein, 1990
). An overview of mutants used in this study is given
in Table 1. The alanine (Ala)-scanned
mutants (nos. 4-7 and 11) have been described previously (Motta
et al., 1995
). Point mutations or deletions in the
cytoplasmic tail of Ii were introduced by polymerase chain reaction
(PCR) mutagenesis using Iiin in the expression
vector pSV51L (Bakke and Dobberstein, 1990
) as template. The forward primers contained the point mutations or deletion and a Kozak translation initiation sequence for proper initiation of translation (Kozak, 1987
). The PCR reactions were performed using Vent DNA polymerase (New England Biolabs, Beverly, MA) for primer extension. The
final PCR products were cloned into pcDNA3 (Invitrogen, Carlsbad, CA).
All mutants were verified by sequencing.
|
Iiwt and IiD6R in the heavy
metal-inducible expression vector pMEP4 (Invitrogen) has been described
(Nordeng and Bakke, 1999
). The C-terminal endosome-binding domain of
early endosomal antigen 1 fused to green fluorescent protein (EEA1-GFP,
McBride et al., 1999
) was a gift from Dr. H. Stenmark (Oslo, Norway).
Cell Culture
Madin-Darby canine kidney strain II (MDCK) and COS-1 cells were grown in complete medium: DMEM (Bio Whittaker, Walkersville, MD) supplemented with 9% fetal calf serum (Integro, Zaandam, Holland), 2 mM glutamine 25 U/ml penicillin, and 25 µg/ml streptomycin (all from Bio Whittaker) in 6% CO2 in a 37°C incubator.
Antibodies and Ligands
The high production in serum-free medium hybridoma BU45-HPSF1
was kindly provided by Dr. S. Buus (Copenhagen, Denmark) and produces
the mouse mAb BU45, which recognizes the luminal C-terminal part of
human Ii (Wraight et al., 1990
). The hybridoma was grown in
protein-free hybridoma medium II supplemented with 100 U/ml penicillin
and 100 µg/ml streptomycin (all purchased from Life Technologies,
Paisly, Scotland). BU43 is a mouse immunoglobulin (Ig) M mAb specific
for the luminal C-terminal part of human Ii (Binding Site, Birmingham,
UK), and the mouse mAb VicY1 recognizes the N terminus of the Ii tail
(Quaranta et al., 1984
) and was a gift from Dr. W. Kapp
(Vienna, Austria). Goat anti-mouse antibody coupled to Alexa 488 was
obtained from Molecular Probes (Leiden, The Netherlands). Texas Red
(TR)-conjugated goat anti-mouse IgM antibody was from the Southern
Biotechnology Association, Inc. (Birmingham, AL).
Transfections
COS cells were transiently transfected by the DEAE-dextran
method essentially as described by Huylebroeck et al.
(1988)
.
MDCK cells stably transfected with Iiwt and
IiD6R have been described (Nordeng and Bakke,
1999
; Gregers, Nordeng, Gilje, Saudlie, and Bakke, unpublished data).
MDCK cells were transfected with EEA1-GFP by the DNA-calcium phosphate
procedure, yielding stable clones as described elsewhere (Wigler
et al., 1979
). Clones expressing moderate levels of EEA1-GFP
were chosen to avoid interference with the endosomal fusion machinery
(McBride et al., 1999
). Resistant clones were selected in
the presence of 500 µg/ml Geneticin (Duchefa, Haarlem, The
Netherlands). Approximately 100% positive clones expressing EEA1-GFP
were then double-transfected with Ii and selected with 300 µg/ml
hygromycin B. Resistant clones were induced with 25 µM
CdCl2 for 16 h to induce Ii expression.
Double-positive clones were identified by immunofluorescence microscopy.
Immunofluorescence Confocal and Video Microscopy
Transfected cells were grown on glass coverslips and allowed to internalize BU43 for 1 h and then fixed with 3% paraformaldehyde. Fixed cells were incubated for 30 min at room temperature with appropriate antibodies diluted in PBS containing 1% sapponin, washed three times with PBS, and incubated for 30 min with goat anti-mouse Alexa 488 antibodies or goat anti-mouse IgM-Texas Red diluted in PBS/1% sapponin to detect bound primary antibody. The coverslips were then washed and mounted in Fluoromount G (Southern Biotechnology Associates, Birmingham, AL). Confocal images were acquired with a Leica TCS-NT digital scanning confocal microscope (Leica Wetzlar, Germany) equipped with a 60/1.2 water immersion objective. Alexa 488 was excited with the 488 line of a krypton-argon laser and imaged with 515-540 bandpass filters, whereas Texas-Red was excited with the 568 line and imaged with long-pass 590 filters. The images were processed for presentation by Photoshop (Adobe Systems, Mountain View, CA). For quantification of ILEV formation, 25 different images per experiment were studied, and vesicles with diameters larger than 1 µm were defined as ILEV. The fraction of cells containing ILEV, the average number of ILEV per cell, and the average size of ILEV were quantified.
Metabolic Labeling, Immunoprecipitation, and Endo H Treatment
COS cells in 35-mm wells were labeled 2 d after transfection, and stably transfected MDCK cells grown in 35-mm wells were grown to ~75% confluency in full medium supplemented with various concentrations of CdCl2. The cells were then starved in Cys/Met-free DMEM for 45 min at 37°C before labeling in the same medium containing 100 µCi/ml 35Cys/35Met for another 30 min. After labeling, the cells were placed on ice, washed three times in ice-cold PBS, and lysed in ice-cold lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Nonidet P-40) containing a cocktail of protease inhibitors (4 µg/ml phenylmethylsulfonyl fluoride, 2 µg/ml antipain, 2 µg/ml leupeptin, and 1 µg/ml pepstatin A) for 20 min. The lysate was centrifuged at 10,000 × g for 10 min at 4°C to remove the cell nuclei and cellular debris, and the supernatant was used directly for immunoprecipitation. Ii proteins were precipitated from the supernatant by addition of BU45 for 1 h at 4°C. Dynabeads (0.25 mg)- sheep anti-mouse IgG (Dynal, Oslo, Norway) were then added for a further incubation for 1 h. The beads-antigen complexes were collected using a Dynal magnetic particle concentrator and washed twice with PBS containing 1% Nonidet P-40. Endo H digestion was performed by resuspending the beads in 0.1 M phosphate buffer (pH 5.5) containing a cocktail of protease inhibitors as described above. The samples were split in two and incubated for 3 h at room temperature with or without Endo H (Boehringer-Mannheim, Mannheim, Germany). After incubation, the proteins were eluted from the beads by incubation in gel-loading buffer (50 mM Tris-HCl, pH 6.8, 2% SDS, 10% glycerol, and 0.1% bromphenol blue) at 95°C for 3 min.
Nonreducing gel electrophoresis was performed in a 12%
SDS-polyacrylamide gel with a 5% stacking gel, prepared as described by Laemmli (1970)
. The gels were fixed in 10% acetic acid-30% methanol, and the radioactive signal was amplified using Amplify solution (Amersham Pharmacia Biotech, Piscataway, NJ). The bands were
detected with the Molecular Imaging Screen CS (Bio-Rad, Hercules, CA)
and analyzed with a Bio-Rad GS-250 Phosphor Imager. The intensity of
each band was quantified by the Molecular Analyst 2.0.1 software (Bio-Rad). The amount of Ii protein was quantified and related to the
total amount of radiolabeled protein in the lysate, giving the relative
Ii protein expression.
NMR Spectroscopy
NMR spectra were recorded on a DRX-500 spectrometer (Bruker,
Newark, DE) equipped with a triple resonance probe head and pulsed field gradients. Proton chemical shift assignments were performed using
conventional two-dimensional experiments as described in Motta et
al., 1997
. Data processing was performed using Aurelia 2.0 software (Bruker Analytic GMBH, Reinstetten, Germany) running on
Silicon Graphics computers (Mountain View, CA).
Structure Calculations
Model building and preliminary calculations were performed on a
United Atom (UA) model (Weiner et al., 1984
) with the Sybyl 6.5 package (Tripos, St. Louis, MO). The solvation effects were roughly
included using a distance-dependent dielectric constant
= r. In the
UA model, distance restraints, as previously derived from NMR spectra
of the wild-type 27-amino acid cytosolic Ii tail, were included as the
C-C or C-N distance increasing the upper limits calculated for
interproton distances of 1 Å. Semiparabolic penalty functions were
used with force constants in energy minimization (EM) and room
temperature molecular dynamics (MD) simulations of 5 kcal
mol
1 rad
2 for dihedral
restraints and 5 kcal mol
1
Å
2 for distance restraints. In simulated
annealing (SA) and preliminary MD runs, a time step of 1 fs, with no
restraint on bond length applied, was used. SA calculations were
performed with different lengths (from 10-250 ps), temperature
(maximum values from 500-800 K, applied for 25-75% of the total
time, cooling rates from 1-5 K ps
1), and
restraint force constant time profiles. After analysis of energy and
violations, the best 40 structures were energy minimized, solvated in a
periodic box of 5120 methanol molecules, and subjected to a 500-ps run
of restrained MD simulations, followed by 1 ns of unrestrained MD run.
EM and MD simulations with solvent were performed with the Sander
module of the Amber 4.1 package using the Amber/OPLS force field
(Jorgensen, 1986
; Jorgensen and Tirado-Rives, 1988
). A time step of 2 fs, with rigid restraining of all bond lengths (SHAKE algorithm,
Ryckaert et al., 1977
) and periodic boundary conditions were
applied. All MD simulations were performed in the isothermal-isobaric ensemble (300 K, 1 atm), with a solvent box that initially extended 8 Å from the most external solute atom on each side of the box. The
final analyses were performed with specific modules of the Amber 4.1, Sybyl 6.5, and Molmol (Koradi et al., 1996
) packages. Molecular structures have been drawn with Molmol and rendered with the
POV-ray software.
Quantification of Cell-free Fusion of Endocytic Vesicles
Cell-free endosome fusion was quantified as previously described
(Gruenberg et al., 1989
; Bomsel et al., 1990
;
Gorvel et al., 1991
). Briefly, 80% confluent cells were
incubated for 30 min with 1.8 mg/ml biotinylated horseradish peroxidase
(bHRP) or 3.6 mg/ml avidin. After washing with PBS/bovine serum
albumin, cells were homogenized in homogenization buffer (250 mM
sucrose, 3 mM immidazole, pH 7.4) by six passes through a
1.25"× 22-G needle, and postnuclear supernatants were prepared.
Aliquots (50 µl) of the two postnuclear supernatants were combined in
the presence of 50 µl of rat liver cytosol (10 mg/ml protein),
adjusted to 12.5 mM HEPES (pH 7.4), 1.5 mM MgOAc, 3 mM imidazole
(pH 7.4), 1 mM dithiothreitol, 50 mM KOAc, and complemented with
8 µl of an ATP-generating system (1:1:1 mixture of 100 mM ATP brought to pH 7.0 with KOH, 800 mM creatine phosphate, and 4 mg/ml creatine kinase) and 8 µl of a 1-mg/ml biotin-insulin stock solution as a
quenching agent. To deplete ATP, 1.6 µl of apyrase (1.200 U/ml) replaced the ATP-generating system. The fusion reaction was carried out
for 45 min at 37°C, eventually in the presence of 1 mM
N-ethylmaleimide (NEM) or 100 nM wortmannin, before Triton
X-100 solubilization. Avidin was then immunoprecipitated, and the
associated HRP was quantified by colorometry.
Materials
All materials, unless specified otherwise, were purchased from Sigma (St. Louis, MO).
| |
RESULTS |
|---|
|
|
|---|
ILEV Formation Depends on the Ii Cytoplasmic Tail N Terminus but Not on Specific Amino Acid Residues
Transient expression of Ii in transfected COS cells causes the
formation of enlarged endosomes (Figure
1). We have used this phenotype, defined
as spheres with a diameter >1 µm, as an assay to study the
structural requirements for vacuolation. The N-terminal 11 first amino
acids of the Ii cytoplasmic tail has previously been shown to be
required for ILEV formation (Pieters et al., 1993
). A panel
of Ii constructs with mutated cytoplasmic tails were therefore
transiently expressed in transfected COS cells and subjected to
immunofluorescence microscopy (Table 1). To identify the minimal region
of the Ii cytoplasmic tail required for vacuolation, we first expressed
two additional deletion mutants. Ii
2-8 (no. 2) did
not induce vacuolation, whereas expression of
Ii
2-5 (no. 3) did, but less extensively than
Iiwt. This indicated that information for
vacuolation was contained within the six first residues in the
cytoplasmic tail of Ii, denoted as the Ii tailpiece. To investigate
whether single amino acids within this region were required for
vacuolation, we substituted all amino acids in positions 2-8 with Ala
residues. Immunofluorescence and phase contrast microscopy analysis
showed that all mutants induced vacuolation to similar extents as
Iiwt (Table 1, nos. 4-7 and 11).
|
From a previous study it was reported that the sorting signal in the
N-terminal region of the cytoplasmic tail,
Leu7Ile8, was not required
for ILEV formation as long as the second signal was kept intact
(Bremnes et al., 1994
). The second Leu signal may also be
replaced with tyrosine-based endosomal sorting signals (from the
transferrin receptor or TGN 38) without affecting vacuolation, showing that vacuolation is not dependent on a specific endosomal sorting signal (Bremnes and Bakke, unpublished data).
Ii harbors four charged amino acids within the N-terminal tailpiece:
three aspartic (Asp) residues and one arginine (Arg) giving a net
negative charge in this region of
2. In addition, previous studies of
Ii trafficking (Pond et al., 1995
) have demonstrated a role
for charged amino acids within the tailpiece of Ii. As noted in Table
1, Ala substitutions, except for construct 11, did not change the
overall charge of the tailpiece and all still induced ILEV formation.
The
2-5 truncation, although presenting a single negative charge
in the tail, also formed ILEV. These data prompted us to ask whether
the charge distribution rather than the specific amino acid sequence
would determine ILEV formation. We studied the role of the charged
residues by introducing amino acids that altered the overall charge
distribution in the tailpiece or by inverting charges at specific
positions. We observed that when the total charge of the N-terminal
tailpiece was negative (nos. 3-10) we always observed vacuolation. In
contrast, a total positive charge (nos. 17-21) always prevented ILEV
formation. However, when the tailpiece had a neutral charge, some
constructs formed ILEV (nos. 11-13), whereas others did not (nos.
14-16). This encouraged us to study in more detail the requirement for negative charges at specific sites. Changing Asp2
to Arg (IiD2R, no. 12) caused ILEV formation. In
contrast, the Asp3 to Arg (construct 14) and
Asp6 to Arg (no. 15) substitutions were
sufficient to prevent vacuolation (Table 1; Figure 1). Similar results
were obtained when Lys was introduced in position 3 or 6, suggesting
that positive charges in these positions prevented vacuolation.
Likewise, when the Asp in position 3 or 6 were replaced with
another acidic residue, Gla, ILEV still formed (data not shown),
indicating that the Asp residue per se was not required, but rather the
presence of a negative charge appeared to be necessary. When both
positions 3 and 6 were exchanged simultaneously for Ala residues (no.
16), vacuolation did not occur, indicating that
Asp2 alone was not sufficient for vacuolation.
Although endosomal distribution of the constructs was confirmed by
immunofluorescence microscopy (Figure 1), the inability of some mutants
to form ILEV could in principle be due to inefficient transport to
endosomes. Hence, transfected COS cells were subjected to metabolic
labeling, immunoprecipitation, and Endo H treatment. Cells expressing
Iiwt, IiD3R, and
IiD6R all gained Endo H resistance, indicating
that a fraction of the proteins was successfully transported out of the
ER to the TGN (Figure 2). However, a
control construct, IiD2R/D3R/D6R (no. 21)
containing two double-Arg ER retention motifs (Schutze et
al., 1994
), was sensitive to Endo H, indicating that most of this
construct did not reach the TGN. These data demonstrate that, except
for IiD2R/D3R/D6R, mutations in the cytoplasmic tailpiece did not significantly affect the intracellular distribution of the resulting Ii constructs.
|
Predicting Vacuolation: The Importance of Available Negative Charges Not Involved in (i, i ± 3) Salt Bridges within the Ii Tailpiece
MD simulations of some of the above constructs helped to explain
the mutation data. For the calculations we relied on the structure
found for the wild-type 27-amino acid peptide. We have reported that an
Ii tail peptide takes up an
-helix that spans the region from
Asp3 to Leu17 with a kink
on Pro15 (Figure
3A; Motta et al., 1995
) and
that it can form a triple-stranded
-helical bundle (Figure 3B) at
high concentration (Motta et al., 1995
). Constructs with
internal Ala substitution induced vacuolation (Table 1) without
affecting the helix and the
2 tailpiece charge. Figure 3C shows MD
simulations of the 27-amino acid peptide corresponding to construct 6 (IiL7A), for which a helix is observed.
Analogously, the structure found for constructs 4 and 7 is
helical. For construct 5 (IiR5A,D6A), Ala
substitution cancels the wild-type
Asp3-Asp6-capping box
(Forood et al., 1993
), thus shortening the helix (Figure
3D). However, the tailpiece charge and the ILEV formation are not
altered (Table 1), and the same is true for construct 11 (IiD2A,D3A, Figure 3E), although the tailpiece
charge is now 0. Construct 14 (IiD3R) is very
interesting because it bears a neutral tail, for which vacuolation is
not observed (Table 1), but MD simulations indicate the presence of a
helix (Figure 3F). Finally, although vacuolation is not observed, a
short helix, similar to that observed for construct 5 (Figure 3D), was
predicted for constructs 17-21, all showing a positive tailpiece.
|
The above data rule out that vacuolation is linked to the helix,
because its different length does not affect ILEV formation. What
appears to be relevant is the presence of an available negative charge
at either position 2, 3, or 6 not engaged in an i ± 3 electrostatic interaction. The electrostatic interactions observed in
the Iiwt and constructs with a neutral tailpiece
are reported in Table 2. It is
interesting to observe that for constructs 14-16 all the negative
charges within the tail are engaged in (i, i ± 3) salt bridges
with Arg, whereas in constructs 11-13 at least one negative charge is
available for further interactions (Table 2). Accordingly, whereas the
former constructs do not vacuolate, the latter do form large vesicles.
|
It could be argued that the above electrostatic interactions are
essentially due to restraints imposed on the N terminus by the presence
of a helix. We therefore studied the solution structure of hexapeptides
corresponding to constructs 14, 15, and 16 (MDRQRD-NH2, MDDQRR-NH2,
and MDAQRA-NH2, respectively) in their amidated
form to avoid the electrostatic contribution of the C terminus. NMR spectra indicated the presence of strong nuclear Overhauser effects between backbone amide protons of residues 3-4 and residues 4-5, as
well as an effect between the
proton of Asp2
and the amide proton of Arg5 in all hexapeptides.
They strongly suggest the presence of a type I
-turn comprising
Asp2-Arg5 for all of them.
Refinement of the structure by MD simulations highlighted the presence
of a hydrogen bond between the Asp2 side chain
and the amide proton of Gln4 backbone NH, as well
as with the side chain of Arg5. Therefore, the
isolated neutral tailpiece assumes a conformation that favors the
network of electrostatic interactions present in wild-type Ii,
independently of the secondary structure that follows. Altogether, the
mutagenesis analysis and MD data show that ILEV formation does not
depend on specific amino acids but on free negative charges within the
Ii cytoplasmic tail, which are available for interactions required for vacuolation.
Vacuolation Depends on the Ii Expression Level
Ii-induced endosomal vacuolation would require that a substantial
amount of Ii is transported to endosomes. We have shown above that the
intracellular routing of Ii and the Ii constructs could not account for
the differences in the ability to induce ILEV. However, it was also
necessary to study in more detail ILEV formation in response to the
expression level. To this end, MDCK cells were stably transfected with
Iiwt or IiD6R under the
control of an inducible metallothionein promoter. Using this system, we previously demonstrated that protein expression was proportional to the
concentration of CdCl2 in the 0-40 µM range
(Nordeng and Bakke, 1999
). The MDCK cells were incubated with various
concentrations of CdCl2 overnight, metabolically
labeled, and lysed, and Ii proteins were immunoprecipitated and
subjected to SDS-PAGE. The amount of protein immunoprecipitated from
the lysate was quantified as described in MATERIALS AND METHODS, and
the protein expression level was related to the
CdCl2 concentration. Cells were also grown on
coverslips and incubated with the same concentration of
CdCl2 as above and labeled for Ii. Figure
4 shows that the fraction of cells
containing ILEV, the average number of ILEVs per cell, as well as the
average size of ILEV increased with augmented Iiwt expression. In contrast, endosomes were
normal-sized when IiD6R was expressed at high
levels similar to Iiwt. This shows that one
specific positively charged amino acid in the Ii cytoplasmic tail is
sufficient to impair the ability of Ii to induce ILEV.
|
Ii-induced Endosome Vacuolation and Fusion Is Insensitive to Wortmannin
The giant size of the ILEV depends on membrane supply, most likely
obtained by endosome fusion, and we have found that ILEV are generated
from a population of early endosomes (Bakke and Nordeng, Nordeng,
Gregers, Kongsvik, Méresse, Gorvel, Jourdan, Motta, and Bakke,
unpublished data). To study the role of early endosome fusion for ILEV
formation, CV1 cells were double-transfected with
Iiwt and rab5lle133, a
dominant negative mutant that inhibits early endosome fusion (Gorvel
et al., 1991
). Whereas the normal phenotype of
rab5lle133 is early endosome fragmentation, we
found by confocal microscopy that ILEV were still formed in
double-transfected cells, and conversely, IiD6R
did not inhibit vacuolation induced by the constitutively active
rab5L79 mutant. This suggested that the
Ii-induced vacuolation was uncoupled from the rab5-regulated endosome
fusion. To study this further, we used wortmannin, a specific inhibitor
of phosphatidylinositol 3 (PI3)-kinase that has been reported
to block fusion of early endosomes in cell-free assays (Jones and
Clague, 1995
; Jones et al., 1998
). We first studied
Ii-induced vacuolation in the presence of wortmannin in live MDCK cells
expressing inducible Iiwt or
IiD6R. We chose to use
IiD6R as a model for cells with normal-sized
vesicles, because this mutant has been shown not to interfere with the
transport capacity of Ii itself and MHC class II (Gregers, Nordeng,
Gilje, Sandlie, and Bakke, unpublished data). Fresh wortmannin was
added to the cells every 1 h, but it had no detectable effect on
the formation of ILEV (Figure 5A).
Moreover, wortmannin had no observable impact on preformed ILEV even
after 8 h of incubation (Figure 5B). The effect of wortmannin on
EEA1 distribtution was studied in cells coexpressing EEA1-GFP. EEA1-GFP
was bound to endosomes throughout the cytoplasm (Figure 5C), but within
5 min after addition of 100 nM wortmannin, EEA1-GFP was relocated to
the cytoplasm, and little visible staining of endosomes could be
detected (Figure 5D). Because wortmannin blocks binding of EEA1 rather
than inducing a release, this indicates that the turnover of EEA1 on
the early endosome membrane is fast, <5 min. Together, the data show
that ILEV formation does not depend on recruitment of rab5 and EEA1 onto endosomal membranes.
|
These results prompted us to ask whether Ii has a role in endosome
fusion, and this was addressed using a cell-free endosome fusion assay.
Cells were incubated with Cd2+ for 3.5 h to
obtain mostly normal-sized Ii-positive endosomes. bHRP or avidin was
then endocytosed for 30 min to label both early and late endosomes. A
cell-free endosome fusion assay was then carried out as described in
MATERIALS AND METHODS. Endosome fusion was dependent on an
ATP-regenerating system both in the presence and absence of Ii
expression and was inhibited by NEM (Figure 6). The data also show that endosomes
from cells expressing Iiwt fused with ~20%
higher efficiency than endosomes from nontransfected cells and cells
transfected with IiD6R (Figure 6). When
wortmannin was added to the fusion mixture, the fusion efficiency was
reduced to 50% in both control cells and cells transfected with
IiD6R, whereas, the fusion efficiency was reduced
by only 10% using endosomes from
Iiwt-transfected cells. When
Iiwt endosomes were fused with IiD6R endosomes in the presence of wortmannin,
there was a 35% reduction in efficiency. The data show that Ii can
complement for wortmannin in endosome fusion. The above data thus
indicate that Ii is able to increase endosome fusion via a mechanism,
which is able to complement for fusion processes inhibited by
wortmannin.
|
| |
DISCUSSION |
|---|
|
|
|---|
The Ii-induced endosomal vacuolation and retention observed in
transfected cells hints for a previously undescribed cell
biological function of Ii. In this study we have attempted to
elucidate the structural requirements for and the mechanism
behind this effect of Ii expression. We have shown that the negative
charges provided by acidic residues in the cytoplasmic tail of Ii are a
prerequisite for ILEV formation. Acidic residues upstream of the
membrane-distal Leu-based sorting signal of Ii have previously been
shown to be necessary for this motif to work efficiently in endosomal
transport (Motta et al., 1995
; Pond et al., 1995
;
Simonsen et al., 1998a
). However, the Leu-based motif per se
is not required for vacuolation, because Ii constructs with the
Leu7Ile8-based motif
inactivated and the
Met16Leu17-based signal
replaced by Tyr-based motifs were also vacuologenic (Nordeng, Gregers,
Kongsvik, Méresse, Gorvel, Jourdan, Motta, and Bakke, unpublished data).
Pond et al. (1995)
found that when the eight N-terminal
residues of the Ii tail, comprising the
Leu7Ile8 signal and the
upstream acidic residues, were replaced by the corresponding region
from the lysosomal integral membrane protein II, M6PR, or CD3
,
vacuolation still occurred. These replacements did not change the
overall negative charge of the tailpiece. However, when the tail was
replaced with the corresponding region of CD4, which lacks an overall
negative charge, vacuolation was not observed (Pond et al.,
1995
). We substituted the Asp residues in position 3 or 6 with Arg in
full-length Ii, changing the net charge in the tailpiece from
2 to
zero, and we found that these single mutations were sufficient to avoid
vacuolation. Intracellular trafficking of the mutants and wild-type Ii
was compared by immunofluorescence microscopy and by quantification of
the fractions of newly synthesized proteins that gained Endo H
resistance, and there is no indication from the results that the
inability of the mutants to form ILEV was due to impaired transport to
the endocytic pathway. Moreover, structural data suggest that
vacuolation can be interpreted in terms of (i, i ± 3)
electrostatic interactions present in the Ii tailpiece. This was
applied as a control to the above chimeric Ii constructs reported by
Pond et al. (1995)
, and we found that for neutral tailpieces
one may explain ILEV formation using the above hypothesis on
electrostatic interactions.
Pond et al. (1995)
sought to reconstitute large vesicle
formation by replacing one or two residues with Asp and obtained
two positive (MDQIKRLL and MSDIKRLL) and one neutral (MDDIKRLL) tail. In agreement with our observations, no large vesicles were observed for
positively charged tails. More interesting, for the neutral one no
large vesicles were formed (Pond et al., 1995
), as it can be
predicted by our electrostatic hypothesis. This is due to the presence
of double (i, i ± 3) electrostatic interactions (between residues
2-5 and 3-6). The results show that Ii-induced vacuolation depends on
available negative charges in the Ii N terminus rather than specific
amino acids residues.
It was previously reported that Ii constructs with deletions in the
luminal domain, which abolished trimerization, did not cause
vacuolation (Gedde-Dahl et al., 1997
). We did not observe ILEV in cells transfected with chimeric constructs in which the Ii tail
was fused to the transmembrane domains of either the transferrin receptor, which is dimeric (Jing and Trowbridge, 1987
), or the neuraminidase, which is a tetramer (Bremnes et al., 1994
).
This suggests that the trimeric conformation of Ii is required for vacuolation. The luminal domain of Ii is sequentially degraded in
endosomes, but the tails remain trimeric (Amigorena et al., 1995
; Newcomb et al., 1996
). Double-staining of ILEV with
antibodies against the luminal and the cytoplasmic domains of Ii has
demonstrated that the cytoplasmic tails are recognized by antibodies in
"late" ILEV after the luminal domain has been degraded (Stang and
Bakke, 1997
).
It has previously been shown that Ii is retained within the endocytic
pathway (Loss and Sant, 1993
) where it induces a delayed endocytic
transport of both antigens and membrane proteins (Romagnoli et
al., 1993
; Amigorena et al., 1995
; Gorvel et
al., 1995
). Use of the protease inhibitor leupeptin showed that
MHC class II accumulated in late endosomes in association with an
Ii-derived fragment, Iip10 (Maric et al., 1994
; Amigorena
et al., 1995
; Brachet et al., 1997
). Iip10
harbors an intact cytoplasmic tail and this led to the suggestion that
a signal for endosomal retention was present in the cytoplasmic tail of
these fragments, which retained MHC class II until Ii processing was
complete. It was further suggested that the retention signal likely was
constituted of the two Leu-based signals (Maric et al.,
1994
). However, in a recent study we have shown that expression of
Iiwt but not IiD6R caused
endocytosed material destined for the TGN or lysosomes to be retained
in endosomes (Gregers et al., unpublished data), suggesting
that endosomal retention is not dependent on the two Leu-based signals.
Instead, available negative charges in the N terminus of Ii seem to be decisive.
In a previous study, we have reported the structure of a synthetic
peptide corresponding to the cytoplasmic tails of
Iiwt determined in solution (Motta et
al., 1997
). At high concentrations, this peptide folds as a
trimeric
-helical bundle. Interestingly, these trimers were almost
coplanar and antiparallel, arranged in an up-down-up orientation,
suggesting that different trimers might interact with each other. This
trimeric association, which preserves the secondary structure of the
monomer, was shown to be mostly determined by the pattern of polar and
hydrophobic residues. NMR spectroscopy was also applied to compare the
solution structure of the synthetic peptides corresponding to the
cytoplasmic tails of Iiwt and
IiD6R, and they were found to have almost the
same overall shape (Motta et al., 1997
). When the
concentration of the Iiwt tail peptide was
increased in methanolic solution, the peptide started to form an
aggregate. Interestingly, in similar conditions, the
IiD6R tail peptide did not aggregate, even after being refrigerated for several months. The absence of aggregation correlates with the lack of noticeable differences in NMR spectra at
various concentrations (Nordeng, Gregers, Kongsvik, Méresse, Gorvel, Jourdan, Motta, and Bakke, unpublished data), suggesting that
internal double-salt bridges
(Asp2-Arg5 and
Asp3-Arg6) alter the charge
distribution within the tailpiece, thus disfavoring the trimeric
association described for the native peptide.
The morphological and structural evidence prompted us to ask for a
possible connection between available negative charges in the
cytoplasmic tail of Ii, the intrinsic aggregating ability of tails
pointing in opposite directions, and the endosomal vacuolation and
delayed endocytic trafficking. We have previously suggested that
interactions between Ii molecules on separate membranes could promote
fusion between endosomes (Motta et al., 1997
). In this scenario, membranes of different endosomes are brought together by
trans interactions between protruding tails. Parton et
al. (1992)
have reported that chemical cross-linking of endosomes in live cells causes vacuolation and partially impaired sorting. Moreover, there are several examples in the literature describing vacuolation in response to increased endosomal fusion (Barbieri et al., 1994
; Stenmark et al., 1994
). We have
searched for a connection between the structural and the morphological
data by applying a cell-free fusion assay for endosome membranes
containing Iiwt or IiD6R.
Data from these experiments show that in the cell-free system Ii
increased endosome fusion by 20%, and it is possible that this could
account for the observed effects on the endosomal pathway.
In vitro homotypic fusion between early endosomes has been reported to
be almost completely blocked by the PI3-kinase inhibitor wortmannin
(Jones and Clague, 1995
). In our cell-free assay, wortmannin inhibited
fusion between endosomes by ~45%. The reason for the lower
efficiency of wortmannin in our assay could be that we used a mixture
of early and late endosomes. However, fusion between endosomes from
cells expressing Iiwt was inhibited by only
~10% when wortmannin was included in the fusion mixture.
IiD6R, on the other hand, was not able to restore
fusion under such conditions. This shows that in the presence of
Iiwt endosome fusion is not dependent on the
PI3-kinase and suggests that this effect depends on free negative
charges within the cytoplasmic tail N terminus.
There are a number of recently discovered proteins that serve to link
vesicles with their targets (for reviews, see Pfeffer, 1999
; Waters and
Pfeffer, 1999
). One of these, EEA1 has been shown to bind PI3-phosphate
on early endosomes (Mills et al., 1998
; Simonsen et
al., 1998b
; Christoforidis et al., 1999
). We observed by live cell microscopy that, although EEA1-GFP rapidly dissociated from endosome membranes upon addition of wortmannin, Ii-induced vacuolation was not sensitive to this treatment. In the presence of
Iiwt, endosome fusion was insensitive to
wortmannin, whereas NEM always blocked fusion. This suggests that Ii
can complement for PI3-kinase activity in a step before the
NEM-sensitive docking of endosomal membranes.
When Iiwt-positive endosomes were mixed with endosomes containing IiD6R, the wortmannin-induced block of endosome fusion was not restored. One possible explanation for this observation is that Iiwt tails could recruit a cytoplasmic factor involved in homotypic endosome fusion and that IiD6R fails to recruit such a factor. Another explanation could be that the cytoplasmic tail of Iiwt is not able to form stable antiparallel interactions with tails of IiD6R. The latter model is supported by NMR calculations showing that electrostatic interactions between the Ii tails depend on available negative charges, which the N-terminal tail of IiD6R does not provide. Thus, although it is possible that relevant cytoplasmic factors could be recruited specifically by the cytoplasmic tail of Ii, we provide evidence that the aggregating property of the Ii cytoplasmic tail is involved in the regulation of endosome fusion.
The PI3-kinase together with rab5 recruit EEA1 to early endosomal
membranes, and it has been suggested that the EEA1 molecules on
separate membranes can tether endosomes together by coiled-coil interactions. This is believed to be an early step in the linkage process ultimately causing early endosomes to fuse (for a review, see
Pfeffer, 1999
; Waters and Pfeffer, 1999
). Our data show that in vitro
the cytoplasmic tail of Ii can partially complement for endosome
tethering by EEA1. Pfeffer (1999)
has defined vesicle tethering as
involving loose links that extend over distances >25 nm, whereas
docking molecules promote rather stable interactions that hold two
membranes within a 5- to 10-nm distance. Interactions between
antiparallel Ii tails are expected to be quite loose but would not hold
membranes with a distance of much more than 5 nm because the tails are
quite short (30 amino acids in
helical conformation,
including a kink). Hence, Ii does not fall into one or the other
category, but we suggest that Ii may serve to stabilize membrane
topology in a conformation that favors SNARE interactions and
subsequent vesicle fusion.
Ii tails have been found on both early and late endosomes (Stang and
Bakke, 1997
), and interactions between the tails could therefore cause
endosome populations to mix. Consequently, vectorial processes such as
transport and proteolysis would be disordered. This theory is supported
by recent experimental data showing that high expression of
Iiwt, but not IiD6R, caused
endocytosed material destined for the TGN or lysosomes to be retained
in endosomes (Gregers et al., unpublished data). Moreover,
antigen presentation of an Ii-dependent epitope was shown to be
enhanced in cells expressing Iiwt compared with
IiD6R. Even though it remains to be elucidated whether, and under which circumstances, Ii is able to regulate its own
intracellular environment in vivo, our data support new aspects of
regulation of endocytic transport and endosome size and morphology.
| |
ACKNOWLEDGMENTS |
|---|
We thank Harald Stenmark and Bjørn Bremnes for helpful discussions. This work was supported by European Community Research Training Networks grant ERBFMRXCT960069 (A.M., F.J., J-P.G, and O.B.). T.F.G and T.W.N were supported by grants from the Norwegian Cancer Society, the Novo Nordisk Foundation, and the Norwegian Research Council.
| |
FOOTNOTES |
|---|
The authors have contributed equally to
this work.
Corresponding author. E-mail address:
oddmund.bakke{at}bio.uio.no.
Article published online ahead of print. Mol. Biol. Cell 10.1091/mbc.01-10-0478. Article and publication date are at www.molbiolcell.org/cgi/doi/10.1091/mbc.01-10-0478.
| |
REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. Beers, A. Burich, M. J. Kleijmeer, J. M. Griffith, P. Wong, and A. Y. Rudensky Cathepsin S Controls MHC Class II-Mediated Antigen Presentation by Epithelial Cells In Vivo J. Immunol., February 1, 2005; 174(3): 1205 - 1212. [Abstract] [Full Text] [PDF] |
||||